Tapping the Brakes on New Parkinson Disease Biological Staging

Njideka U Okubadejo¹, Michael S Okun^{2

3}, Joseph Jankovic⁴

Affiliations

¹ Neurology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Nigeria.
² Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida Health, Gainesville.
³ Associate Editor, JAMA Neurology.
⁴ Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.

Njideka U Okubadejo et al. JAMA Neurol. 2024.

. 2024 Aug 1;81(8):789-790.

doi: 10.1001/jamaneurol.2024.2054.

Njideka U Okubadejo¹, Michael S Okun^{2

3}, Joseph Jankovic⁴

¹ Neurology Unit, Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Nigeria.
² Norman Fixel Institute for Neurological Diseases, Department of Neurology, University of Florida Health, Gainesville.
³ Associate Editor, JAMA Neurology.
⁴ Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.

No abstract available

Plain language summary

This Viewpoint cautions against the premature adoption and implementation of biological definitions for Parkinson disease proposed in February 2024.